Q3 2025 net revenue of $26.1 million, driven by MIPLYFFA® net revenue of $22.4 million Company to host conference call and webcast TODAY, November 5, 2025, at 4:30 p.m. ET CELEBRATION, Fla., Nov. 05, ...
Arabidopsis thaliana was always an unlikely candidate for the limelight. But 25 years ago, the diminutive thale cress ...
Q3 2025 Earnings Call Transcript November 4, 2025 SOPHiA GENETICS S.A. misses on earnings expectations. Reported EPS is $-0.3 ...
News Medical on MSN
Stress hormones silence key brain genes through chromatin-bound RNAs, study reveals
Priority Research Communication by Professor Yogesh Dwivedi and colleagues at the University of Alabama at Birmingham reports original, peer-reviewed findings demonstrating that long noncoding RNAs ...
Inclusion in the ENDO 1000 study in the UK for multiple sample types is presented as evidence of market validation for OraSure Technologies' collection kits, as described in the Q3 2025 earnings call, ...
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurological disorder causing motor neuron death, leading to muscle ...
Myriad Genetics (MYGN) stock is downgraded from a "Buy" to "Hold" due to flat Q3 2025 earnings and limited near-term revenue ...
Catechins are the heart of tea’s flavor and health-promoting properties, especially the galloylated types such as EGCG and ...
Lise Barnéoud's Hidden Guests shows how this fascinating new field brings with it profound implications for medicine, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback